Hydrogen Sulfide Attenuates Lymphedema Via the Induction of Lymphangiogenesis Through a PI3K/Akt‐Dependent Mechanism
Open Access
- 1 November 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (21) , e026889
Abstract
Background: Accumulating evidence suggests that hydrogen sulfide ( H 2 S ), an endogenously produced gaseous molecule, plays a critical role in the regulation of cardiovascular homeostasis. However, little is known about its role in lymphangiogenesis. Thus, the current study aimed to investigate the involvement of H 2 S in lymphatic vessel growth and lymphedema resolution using a murine model and assess the underlying mechanisms. Methods and Results: A murine model of tail lymphedema was created both in wild‐type mice and cystathionine γ‐lyase–knockout mice, to evaluate lymphedema up to 28 days after lymphatic ablation. Cystathionine γ‐lyase–knockout mice had greater tail diameters than wild‐type mice, and this phenomenon was associated with the inhibition of reparative lymphangiogenesis at the site of lymphatic ablation. In contrast, the administration of an H 2 S donor, diallyl trisulfide, ameliorated lymphedema by inducing the formation of a considerable number of lymphatic vessels at the injured sites in the tails. In vitro experiments using human lymphatic endothelial cells revealed that diallyl trisulfide promoted their proliferation and differentiation into tube‐like structures by enhancing Akt (protein kinase B) phosphorylation in a concentration‐dependent manner. The blockade of Akt activation negated the diallyl trisulfide–induced prolymphangiogenic responses in lymphatic endothelial cells. Furthermore, the effects of diallyl trisulfide treatment on lymphangiogenesis in the tail lymphedema model were also negated by the inhibition of phosphoinositide 3'‐kinase (P13K)/Akt signaling. Conclusions: H 2 S promotes reparative lymphatic vessel growth and ameliorates secondary lymphedema, at least in part, through the activation of the Akt pathway in lymphatic endothelial cells. As such, H 2 S donors could be used as therapeutics against refractory secondary lymphedema.Keywords
This publication has 51 references indexed in Scilit:
- Lymphedema and Therapeutic LymphangiogenesisBioMed Research International, 2013
- Adiponectin‐Mediated Modulation of Lymphatic Vessel Formation and LymphedemaJournal of the American Heart Association, 2013
- Therapeutic Lymphangiogenesis With Implantation of Adipose‐Derived Regenerative CellsJournal of the American Heart Association, 2012
- Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxationProceedings of the National Academy of Sciences of the United States of America, 2012
- 9-Cis Retinoic Acid Promotes Lymphangiogenesis and Enhances Lymphatic Vessel RegenerationCirculation, 2012
- Hydrogen sulphide and angiogenesis: mechanisms and applicationsBritish Journal of Pharmacology, 2011
- Cystathionine γ-Lyase-deficient Mice Require Dietary Cysteine to Protect against Acute Lethal Myopathy and Oxidative InjuryJournal of Biological Chemistry, 2010
- Genetic and Pharmacologic Hydrogen Sulfide Therapy Attenuates Ischemia-Induced Heart Failure in MiceCirculation, 2010
- Novel Insights Into Hydrogen Sulfide–Mediated CytoprotectionAntioxidants & Redox Signaling, 2010
- Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioningJournal of Cell Biology, 2006